New York Life Investment Management Q2 2026 Portfolio Changes: Strategic Shifts in Tech Stocks
This report details observable purchases and sales by New York Life Investment Management Llc during its second quarter filing for the period ending June 30, 2026.
During the second quarter of 2026, New York Life Investment Management Llc, a significant institutional investor, demonstrated notable activity in its portfolio. The analysis focuses on changes observed compared to the previous quarter.
Prominent Purchases This Quarter
New York Life Investment Management showed strong buying momentum during Q2 2026, adding substantial shares to several holdings and establishing new positions. The most significant purchase was observed in Franklin Templeton ETF TR (FLBL), where the firm increased its stake by a remarkable 58.27%. This translates to acquiring an additional 1,571,463 shares of this fund trust.
Additionally, the investor significantly boosted its position in SPDR Series Trust (SPHY) by 289.12%, acquiring 716,537 new shares during this period.
Furthermore, substantial additions were noted in Vanguard Index Fds (VO), INVESCO DB US DLR INDEX TR (UUP), and ABRDN ETFS (BCI). The increase in UUP was particularly large, representing a 956.35% jump from the prior quarter.
Prominent Sales This Quarter
In contrast to its buying activities, New York Life Investment Management also exhibited significant selling during Q2 2026. The largest sale was observed in Vanguard Scottsdale Fds (VGSH), where the firm disposed of a substantial portion of its holdings, reducing them by an impressive 33.17%. This resulted in a net reduction of 1,526,211 shares.
Other notable disposals included Organon & Co (OGN), where the entire position was sold (100% change). Similarly, Global Business Travel Group (GBTG) and Esperion Therapeutics Inc. NE (ESPR) saw their positions completely liquidated during this quarter.
Additional Activity Observed
The investor also made smaller adjustments to other holdings. For instance, Olaplex Hldgs Inc. (OLPX), SPDR Series Trust (FLRN), and J P Morgan Exchange Traded Fund (JEPI) were added with moderate increases (100% change) or smaller additions, but these represent less than a 58.27% increase compared to the largest purchase.
Conversely, minor reductions were noted in stocks like AES Corp (AES) and INVESCO DB US DLR INDEX TR (UUP), although these are significantly overshadowed by the large sales observed elsewhere. The sale of UUP was particularly noteworthy despite its previous size, showing a complex picture of institutional activity.
Overall Portfolio Context
The changes tracked during Q2 2026 reflect New York Life Investment Management's dynamic investment strategy focused on capitalizing on market movements and specific opportunities. The filing indicates the firm holds a diverse portfolio with holdings across various sectors, including Technology, Consumer Cyclical, Healthcare, Financial Services, and others.
The data provided offers valuable insights into how this large institutional investor is allocating capital in real-time based on performance metrics and changing market dynamics during the period ending June 30, 2026. Further details can be explored by visiting their official profile or examining individual stock positions.